<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617587</url>
  </required_header>
  <id_info>
    <org_study_id>GR-2018-12365280</org_study_id>
    <nct_id>NCT04617587</nct_id>
  </id_info>
  <brief_title>Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood</brief_title>
  <official_title>Structural Variations of the Neural Genome as Prognostic Biomarkers for Prematurity Related Neurodevelopmental Disorders in Childhood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministero della Salute, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto Nazionale di Genetica Molecolare, Milan Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Humanitas Milan Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preterms are early exposed to a stressful environment (i.e. excessive sensory stimulation and&#xD;
      paucity of parental contact) with subsequent detrimental effects on brain maturation and&#xD;
      neurodevelopmental outcomes. In contrast, early interventions seem to reduce stress exposure&#xD;
      and promote neurodevelopment. The brain functional plasticity in response to environmental&#xD;
      experiences can be partly attributed to changes in DNA methylation. In this context, LINE-1&#xD;
      (L1) promoter (18% of human genome) methylation/demethylation has been associated with L1&#xD;
      somatic mobilization in the brain genomes, contributing to experience-driven brain&#xD;
      plasticity; this mechanism being deregulated in important neurological disease. This study&#xD;
      aims at identifying and characterizing the role of L1 DNA repeats as a novel biomarker to&#xD;
      predict long-term neurodevelopmental outcome in preterm infants. In addition, the study's&#xD;
      secondary goal will be to define a preventive approach, based on early intervention&#xD;
      strategies, for improving long-term neurodevelopmental outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Around 25-50% of very preterm infants suffer from neurodevelopmental delays (motor, cognitive&#xD;
      and behavioral problems), which are most likely related to brain micro-structural defects and&#xD;
      impaired neuronal maturation and connectivity. These alterations in brain maturation&#xD;
      occurring during the neonatal period may be implicated in long-term neurobehavioral disorders&#xD;
      later experienced by preterm babies.&#xD;
&#xD;
      There is increasing evidence that also stressful events (excessive sensory stimulation,&#xD;
      paucity of parental contact and painful procedures) experienced in the Neonatal Intensive&#xD;
      Care Unit (NICU) by preterm neonates can affect neurodevelopment through epigenetic&#xD;
      mechanisms.&#xD;
&#xD;
      The brain is a genomic mosaic, owing to somatic mutations that arise throughout development.&#xD;
      It is already established that mobile genetic elements, including LINE-1 (L1), are one source&#xD;
      of somatic mosaicism, inducing copy number variations in neural genome. Environmental&#xD;
      experiences can drive brain plasticity at a molecular level, with changes in DNA methylation.&#xD;
      In particular, L1 promoter methylation/demethylation is already associated with L1&#xD;
      mobilization in the brain genomes and its deregulation is linked with important neurological&#xD;
      diseases. A preliminary study has shown the correlation between L1 promoter methylation&#xD;
      levels and preterm birth. In addition, maternal care during early life has been reported to&#xD;
      drive variability in L1 mobilization and methylation of the neural hippocampal genome in mice&#xD;
      models.&#xD;
&#xD;
      Several studies have reported how individualized developmental care in the NICU can&#xD;
      ameliorate preterm infants' medical outcome and subsequent neurodevelopment. More recently,&#xD;
      early intervention (EI) strategies based on parental training and multisensory stimulation,&#xD;
      such as infant massage and visual stimulation, have been demonstrated to enhance child's&#xD;
      neurodevelopment. These programs have the greatest potential to reduce environmental stress&#xD;
      in preterms, promoting brain plasticity, optimizing dyadic interaction and ameliorating&#xD;
      neurodevelopmental outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 3, 2020</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>L1 Promoter Methylation Levels on Biological Materials</measure>
    <time_frame>Up to 24 months corrected age</time_frame>
    <description>Epigenetic analysis is performed on biological materials: cord blood sample and buccal swab at birth, peripheral blood sample and buccal swab at NICU discharge/term equivalent age, buccal swab collected during the follow up assessment at 12 and 24 months of corrected age.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Conventional and advanced brain Magnetic Resonance Imaging (MRI)</measure>
    <time_frame>Term equivalent age, approximately 40 weeks postmenstrual age</time_frame>
    <description>Evaluation of brain development and maturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Examination</measure>
    <time_frame>Term equivalent age, approximately 40 weeks postmenstrual age</time_frame>
    <description>Hammersmith Neonatal Neurological Examination (HNNE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Movements Examination</measure>
    <time_frame>Term equivalent age, approximately 40 weeks postmenstrual age</time_frame>
    <description>Prechtl's Qualitative Assessment of General Movements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Assessment</measure>
    <time_frame>Term equivalent age, approximately 40 weeks postmenstrual age</time_frame>
    <description>Neonatal Visual Assessment Battery developed by Ricci et al. The assessment evaluates the following items: ocular spontaneous motility, ability to fix and follow a target, reaction to colour, visual acuity and visual attention at distance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental Outcome</measure>
    <time_frame>Up to 24 months corrected age</time_frame>
    <description>Children development assessed using the Griffiths Mental Development Scales, performed at 12 and 24 months of corrected age. Mean score is 100. General score has a Standard deviation of 12 and sub scales have a Standard Deviation of 16.&#xD;
Higher scores indicate better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral Outcome</measure>
    <time_frame>24 months corrected age</time_frame>
    <description>Children behavior assessed using the Child Behavior Checklist (CBCL). It is a parent report form to screen for emotional, behavioral and social problems.&#xD;
Lower scores indicate better outcomes. A T score above 75 is considered pathological while a T score between 65 and 74 is considered borderline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Early Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All the enrolled preterm infants are assigned to receive the early neurodevelopmental intervention during the NICU stay.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Early Intervention</intervention_name>
    <description>The early intervention (EI) is delivered during the NICU stay. It is a multisensory intervention which consists in three parts: parental training, massage therapy and visual interaction. The EI is first focused on parental training, according to PremieStart Protocol, in order to train parents to: recognize signs of infant stress and alert-available behavior through the identification of infant's behavioral states; adopt principles of graded stimulation; sustain infant's attention and respond to infant's cues; optimize interactions and avoid overwhelming infants through facilitation strategies. The program is held in eight main sessions and one additional post-discharge session. In addition, parents are trained and invited to daily promote preterm baby massage therapy and visual interaction (visual fixation/tracking and visual attention).</description>
    <arm_group_label>Early Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gestational age at birth between 24+0 and 32+6 weeks&#xD;
&#xD;
          -  Mothers age over 18 years&#xD;
&#xD;
          -  Good comprehension of the Italian language&#xD;
&#xD;
          -  Written informed consent signed by both parents&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infants with major genetic disorders and malformations&#xD;
&#xD;
          -  Parents declined study participation&#xD;
&#xD;
          -  Single-parent family&#xD;
&#xD;
          -  Parents with obvious cognitive or psychiatric disorders and drug addiction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monica Fumagalli, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beatrice Bodega, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Fumagalli, MD, PhD</last_name>
    <phone>+39.0255032951</phone>
    <email>monica.fumagalli@unimi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beatrice Bodega, PhD</last_name>
    <phone>+39.0200660302</phone>
    <email>bodega@ingm.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NICU, Fondazione IRCCS CÃ  Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Fumagalli, MD, PhD</last_name>
      <phone>+39.0255032951</phone>
      <email>monica.fumagalli@unimi.it</email>
    </contact>
    <contact_backup>
      <last_name>Beatrice Bodega, PhD</last_name>
      <phone>+39.0200660302</phone>
      <email>bodega@ingm.org</email>
    </contact_backup>
    <investigator>
      <last_name>Camilla Fontana, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica Marasca, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ida Sirgiovanni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Livia Provitera, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chiara Bonfanti, BsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Fontana C, De Carli A, Ricci D, Dessimone F, Passera S, Pesenti N, Bonzini M, Bassi L, Squarcina L, Cinnante C, Mosca F, Fumagalli M. Effects of Early Intervention on Visual Function in Preterm Infants: A Randomized Controlled Trial. Front Pediatr. 2020 Jun 4;8:291. doi: 10.3389/fped.2020.00291. eCollection 2020.</citation>
    <PMID>32582595</PMID>
  </reference>
  <reference>
    <citation>Newnham CA, Milgrom J, Skouteris H. Effectiveness of a modified Mother-Infant Transaction Program on outcomes for preterm infants from 3 to 24 months of age. Infant Behav Dev. 2009 Jan;32(1):17-26. doi: 10.1016/j.infbeh.2008.09.004. Epub 2008 Nov 20.</citation>
    <PMID>19026450</PMID>
  </reference>
  <reference>
    <citation>Bedrosian TA, Quayle C, Novaresi N, Gage FH. Early life experience drives structural variation of neural genomes in mice. Science. 2018 Mar 23;359(6382):1395-1399. doi: 10.1126/science.aah3378.</citation>
    <PMID>29567711</PMID>
  </reference>
  <reference>
    <citation>Ricci D, Romeo DM, Serrao F, Cesarini L, Gallini F, Cota F, Leone D, Zuppa AA, Romagnoli C, Cowan F, Mercuri E. Application of a neonatal assessment of visual function in a population of low risk full-term newborn. Early Hum Dev. 2008 Apr;84(4):277-80. Epub 2007 Nov 8.</citation>
    <PMID>17996405</PMID>
  </reference>
  <reference>
    <citation>Guzzetta A, Baldini S, Bancale A, Baroncelli L, Ciucci F, Ghirri P, Putignano E, Sale A, Viegi A, Berardi N, Boldrini A, Cioni G, Maffei L. Massage accelerates brain development and the maturation of visual function. J Neurosci. 2009 May 6;29(18):6042-51. doi: 10.1523/JNEUROSCI.5548-08.2009.</citation>
    <PMID>19420271</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Premature Birth</keyword>
  <keyword>DNA Methylation</keyword>
  <keyword>L1 Elements</keyword>
  <keyword>Epigenometics</keyword>
  <keyword>Early Intervention</keyword>
  <keyword>Brain Development</keyword>
  <keyword>Neurodevelopment</keyword>
  <keyword>Parent-infant interaction</keyword>
  <keyword>Massage therapy</keyword>
  <keyword>Visual interaction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Neurodevelopmental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The dataset generated for this study will be made available on request in an anonymized version or in a grouped form in order to prevent patient identification.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

